| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |